Inactive/Delisted stock
Shattuck Labs Stock (NASDAQ:STTK)
Previous Close
$1.33
52W Range
$0.94 - $11.76
50D Avg
$1.24
200D Avg
$2.73
Market Cap
$58.72M
Avg Vol (3M)
$181.49K
Beta
1.67
Div Yield
-
STTK Company Profile
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.